Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phenylenediamines | 1 | 2012 | 2 | 0.420 |
Why?
|
Carbamates | 1 | 2012 | 5 | 0.410 |
Why?
|
Epilepsies, Partial | 1 | 2012 | 5 | 0.410 |
Why?
|
Anticonvulsants | 1 | 2012 | 19 | 0.410 |
Why?
|
Dopamine Agonists | 1 | 2007 | 1 | 0.280 |
Why?
|
Restless Legs Syndrome | 1 | 2007 | 3 | 0.280 |
Why?
|
Tetrahydronaphthalenes | 1 | 2007 | 5 | 0.280 |
Why?
|
Thiophenes | 1 | 2007 | 14 | 0.280 |
Why?
|
Parkinson Disease | 1 | 2007 | 38 | 0.270 |
Why?
|
Pharmacy Residencies | 2 | 2014 | 6 | 0.230 |
Why?
|
Brain Ischemia | 2 | 2013 | 80 | 0.200 |
Why?
|
Practice Guidelines as Topic | 2 | 2013 | 233 | 0.190 |
Why?
|
Phenytoin | 2 | 1990 | 15 | 0.180 |
Why?
|
Stroke | 2 | 2013 | 233 | 0.170 |
Why?
|
Education, Pharmacy | 2 | 2014 | 104 | 0.150 |
Why?
|
Drug Utilization | 1 | 1997 | 28 | 0.140 |
Why?
|
Prenatal Care | 1 | 1997 | 40 | 0.140 |
Why?
|
Students, Pharmacy | 1 | 2014 | 74 | 0.110 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2012 | 9 | 0.100 |
Why?
|
Drug Interactions | 1 | 2012 | 77 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 588 | 0.090 |
Why?
|
Food, Formulated | 1 | 1990 | 11 | 0.090 |
Why?
|
Research | 2 | 2014 | 88 | 0.090 |
Why?
|
Enteral Nutrition | 1 | 1990 | 21 | 0.090 |
Why?
|
Humans | 9 | 2014 | 26856 | 0.080 |
Why?
|
Administration, Cutaneous | 1 | 2007 | 18 | 0.070 |
Why?
|
Patient Advocacy | 1 | 2005 | 16 | 0.060 |
Why?
|
Health Services for the Aged | 1 | 2005 | 13 | 0.060 |
Why?
|
Pharmacy Service, Hospital | 1 | 2005 | 14 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 206 | 0.060 |
Why?
|
Community Pharmacy Services | 1 | 2005 | 22 | 0.060 |
Why?
|
Treatment Outcome | 1 | 2007 | 2267 | 0.040 |
Why?
|
Animals | 1 | 2012 | 9954 | 0.040 |
Why?
|
Nonprescription Drugs | 1 | 1997 | 7 | 0.040 |
Why?
|
Risk Factors | 2 | 2013 | 2017 | 0.040 |
Why?
|
Hospitals, University | 1 | 1997 | 26 | 0.040 |
Why?
|
Drug Prescriptions | 1 | 1997 | 43 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 1997 | 87 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 1997 | 240 | 0.030 |
Why?
|
Pharmacists | 1 | 2014 | 69 | 0.030 |
Why?
|
Oklahoma | 1 | 1997 | 971 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2014 | 28 | 0.030 |
Why?
|
Mechanical Thrombolysis | 1 | 2013 | 3 | 0.030 |
Why?
|
Pregnancy | 1 | 1997 | 1130 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2013 | 36 | 0.030 |
Why?
|
Primary Prevention | 1 | 2013 | 25 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2013 | 45 | 0.030 |
Why?
|
Communication | 1 | 2014 | 167 | 0.020 |
Why?
|
Blood Pressure | 1 | 2013 | 351 | 0.020 |
Why?
|
Dialysis | 1 | 1990 | 4 | 0.020 |
Why?
|
Suspensions | 1 | 1990 | 6 | 0.020 |
Why?
|
Membranes, Artificial | 1 | 1990 | 26 | 0.020 |
Why?
|
Gastroscopy | 1 | 1990 | 7 | 0.020 |
Why?
|
Catheterization | 1 | 1990 | 50 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1990 | 261 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1990 | 128 | 0.020 |
Why?
|
Temperature | 1 | 1990 | 207 | 0.020 |
Why?
|
United States | 1 | 2014 | 2035 | 0.020 |
Why?
|
Protein Binding | 1 | 1990 | 631 | 0.020 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2005 | 6 | 0.020 |
Why?
|
Life Expectancy | 1 | 2005 | 20 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2005 | 58 | 0.020 |
Why?
|
Assisted Living Facilities | 1 | 2005 | 17 | 0.020 |
Why?
|
Health Care Costs | 1 | 2005 | 51 | 0.020 |
Why?
|
Nursing Homes | 1 | 2005 | 43 | 0.020 |
Why?
|
Patient Care Team | 1 | 2005 | 62 | 0.020 |
Why?
|
Data Collection | 1 | 2005 | 101 | 0.020 |
Why?
|
Adult | 1 | 1997 | 7389 | 0.020 |
Why?
|
Quality of Life | 1 | 2005 | 463 | 0.010 |
Why?
|
Female | 1 | 1997 | 14462 | 0.010 |
Why?
|
Aged | 1 | 2005 | 5169 | 0.010 |
Why?
|